Interest of routine measurement of serum calcitonin: Study in a large series of thyroidectomized patients

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 338-341

  Niccoli, Patricia ^a,b   Wion Barbot, Nelly ^c   Caron, Philippe ^e   Henry, Jean Francois ^a   De Micco, Catherine ^a   Saint Andre, Jean Pierre ^d   Bigorgne, Jean Claude ^c   Modigliani, Elisabeth ^f   Conte Devolx, Bernard ^a  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Service d'Endocrinologie   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e CHU RANGUEIL   (France)

^f AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; PENTAGASTRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELIABILITY; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

EID: 0031032927     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.2.3737     Document Type: Article

References (27)

1. Tsai MS, Ledger GA, Khosla S, Gharib H, Thibodeau SN. 1994 Identification of multiple endocrine neoplasia type 2 gene carriers using linkage analysis and analysis of the ret proto-oncogene. J Clin Endocrinol Metab. 78:1261-1264.
2. Schuffenecker I, Billaud M, Calender A, et al. 1994 Ret proto-oncogene mutations in French NEM 2A and FMTC families. Hum Mol Genet. 3:1939-1343.
3. Cornelis JM, Lips MD, Landswater RM, et al. 1994 Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 331:828-835.
4. Rosenberg-Bourgin M, Gardet P, De Sab R, et al. 1989 Comparison of sporadic and hereditary forms of medullary thyroid carcinoma. Henry Ford Hosp Med J. 37:141-143.
5. Gagel RF, Robinson MF, Donovan DT, Alfort BR. 1993 Medullary thyroid carcinoma: recent progress [Clinical Review]. J Clin Endocrinol Metab. 76:809-814.
6. Marsh DJ, Learoyd DL, Robinson BG. 1995 Medullary thyroid carcinoma: recent advances and management update. Thyroid. 5:407-424.
7. Wells SA. 1994 New approaches to the patient with medullary thyroid carcinoma of the thyroid gland. Thyroid Today. 17-4:1-10.
8. Schröder S, Böcker W, Baisch H, et al. 1988 Prognostic factors in medullary thyroid carcinoma. Cancer. 61:806-816.
9. Duh QY, Sancho JJ, Greenspan FS, et al. 1989 Medullary thyroid carcinoma: the need for early diagnosis and total thyroidectomy. Arch Surg. 124:1206-1210.
10. Barbot N, Schuffenecker I, Calmettes C, Modigliani E, Lenoir G, Bigorgne JC. 1993 Conditions actuelles du dépistage du cancer médullaire de la thyroide. Rev Franc Endocrinol Clin. 34:539-548.
11. Barbot N, Calmettes C, Schuffenecker I, et al. 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Enclocrinol Metab. 78:114-120.
12. Marsh DJ, McDowallD, Hyland VJ, et al. 1996 The identification of false positive responses to pentagastrin stimulation test in ret mutation negative members of MEN 2A families. Clin Endocrinol (Oxf). 44:213-220.
13. Seth R, Motté P, Kehely A, et al. 1988 Sensitive and specific two-site enzyme immunoassay for human calcitonin using monoclonal antibodies. J Endocrinol. 119:351-357.
14. Guilloteau D, Perdrisot R, Calmeltes C, et al. 1990 Diagnosis of medullary thyroid carcinoma of the thyroid by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MTC. J Clin Endocrinol Metab. 71:1064-1067.
15. Motté P, Vauzelle P, Gardet P, et al. 1988 Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin Chim Acta. 174:35-54.
16. Sheppard MC. 1995 Should serum calcitonin be measured routinely in all patients with nodular thyroid disease? Clin Endocrinol (Oxf). 42:451-452.
17. Pacini F, Fontanelli M, Fugazzola L, et al. 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 78:826-829.
18. Rieu M, Lame MC, Richard A, et al. 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnosic evaluation of thyroid nodules. Clin Endocrinol (Oxf). 42:453-460.
19. Albores-Saavedra J, Monforte H, Nadji M, Morales AR. 1988 C-Cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. Hum Pathol. 19:795-799.
20. Guyetant S, Wion-Barbot N, Rousselet MC, et al. 1994 C-Cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective study of 112 cases. Hum Pathol. 25:414-421.
21. Barbot N, Guyetant S, Beldent V, et al. 1991 Thyroïdite chronique autoimmune et hyperplasie des cellules C. Etude de la sécrétion de calcitonine chez. 24 patients. Ann Endocrinol (Paris). 52:109-112.
22. Biddinger PW, Brennan MF, Rosen PP. 1991 Symptomatic C cell hyperplasia associated with chroniclymphocytic thyroiditis. Am J Surg Pathol. 15:599-604.
23. Libbey NP, Nowakowski KJ, Tucci JR. 1989 C Cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis. Am J Surg Pathol. 13:71-77.
24. Albores-Salvedra J. 1989 C cell hyperplasia. Am J Surg Pathol. 13:987-988.
25. De Micco C. 1990 Immunohistochimie des carcinomes thyroïdiens. Ann Pathol. 10:297-312.
26. Wolfe H, Kaplan M, Cummings T, et al. 1992 Re-evaluation of histologic criteria for C cell hyperplasia in MEN 2A using genetic recombinant markers [Abstract]. Henry Ford Hosp Med J. 40:312.
27. Gagel RF. 1996 The abnormal pentagastrin test. Clin Endocrinol (Oxf). 44: 221-222